Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.
about
Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic CancerFocal adhesion kinase inhibitor PF573228 and death receptor 5 agonist lexatumumab synergistically induce apoptosis in pancreatic carcinoma.Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells.Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
P2860
Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Development of high-content ge ...... stant pancreatic tumour cells.
@en
Development of high-content ge ...... stant pancreatic tumour cells.
@nl
type
label
Development of high-content ge ...... stant pancreatic tumour cells.
@en
Development of high-content ge ...... stant pancreatic tumour cells.
@nl
prefLabel
Development of high-content ge ...... stant pancreatic tumour cells.
@en
Development of high-content ge ...... stant pancreatic tumour cells.
@nl
P2093
P2860
P1476
Development of high-content ge ...... istant pancreatic tumour cells
@en
P2093
Hongtao Xu
Joanne Lim
Linda Duxfield
Wenli Zhang
P2860
P304
P356
10.1007/S11095-014-1353-Z
P577
2014-03-18T00:00:00Z